Market revenue in 2023 | USD 676.7 million |
Market revenue in 2030 | USD 1,037.9 million |
Growth rate | 6.3% (CAGR from 2023 to 2030) |
Largest segment | Preserved multi-dose eye droppers |
Fastest growing segment | Preservative-free multi-dose eye droppers |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Unidose eye droppers, Preserved multi-dose eye droppers, Preservative-free multi-dose eye droppers |
Key market players worldwide | AptarGroup Inc, Silgan Holdings Inc, Alcon Inc, Pfizer Inc, Bausch & Lomb Corp, Novartis AG ADR, AbbVie Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic eye droppers market will help companies and investors design strategic landscapes.
Preserved multi-dose eye droppers was the largest segment with a revenue share of 49.9% in 2023. Horizon Databook has segmented the Germany ophthalmic eye droppers market based on unidose eye droppers, preserved multi-dose eye droppers, preservative-free multi-dose eye droppers covering the revenue growth of each sub-segment from 2018 to 2030.
The growing prevalence of ophthalmic disorders, such as glaucoma, dry eyes, allergies, and others, in Germany, necessitating the use of ophthalmic eye droppers for its treatment, is expected to contribute to market growth. Aging is one of the major risk factors for ophthalmic disorders.
According to World Bank Data, in 2022, the total population of Germany aged 65 years & above was 22.4% and is anticipated to rise during the forecast period. In addition, Germany witnessed the highest number of specialist visits for DED treatment in Europe.
This signifies high awareness about the importance and benefits of treating DED across Germany. Hence, the increasing ophthalmologist visits and growing awareness about ophthalmic eye drops are expected to contribute to market growth in Germany.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany ophthalmic eye droppers market , including forecasts for subscribers. This country databook contains high-level insights into Germany ophthalmic eye droppers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account